Aggrenox, a new aspirin and dipyridamole combination

Boehringer Ingelheim is now introducing Aggrenox, a new aspirin and dipyridamole prevent stroke in patients who have already had an ischemic stroke or TIA.

Dipyridamole fell out of favor years ago because there wasn't enough evidence to show that it was effective.

But now there's convincing evidence that Aggrenox is MORE effective than aspirin alone to prevent recurrent stroke.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote